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Abstract 
The novel coronavirus disease, named COVID-19, emerged in China in 
December 2019, and has rapidly spread around the world. It is clearly urgent to fight 
COVID-19 at global scale. The development of methods for identifying drug uses based 
on phenotypic data can improve the efficiency of drug development. However, there 
are still many difficulties in identifying drug applications based on cell picture data. 
This work reported one state-of-the-art machine learning method to identify drug uses 
based on the cell image features of 1024 drugs generated in the LINCS program. 
Because the multi-dimensional features of the image are affected by non-experimental 
factors, the characteristics of similar drugs vary greatly, and the current sample number 
is not enough to use deep learning and other methods are used for learning optimization. 
As a consequence, this study is based on the supervised ITML algorithm to convert the 
characteristics of drugs. The results show that the characteristics of ITML conversion 
are more conducive to the recognition of drug functions. The analysis of feature 
conversion shows that different features play important roles in identifying different 
drug functions. For the current COVID-19, Chloroquine and Hydroxychloroquine 
achieve antiviral effects by inhibiting endocytosis, etc., and were classified to the same 
community. And Clomiphene in the same community inibited the entry of Ebola Virus, 
indicated a similar MoAs that could be reflected by cell image. 
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Introduction 
Emerging coronavirus disease 2019, known as COVID-19, is caused by the SARS-
CoV-2 virus identified. Since the outbreak of COVID-19 in December 2019 in Wuhan, 
more than 80 thousand patients were affected in China and meanwhile nearly one 
million patients were affected all over the world. The disease resulted in more than 100 
thousand deaths by April 15 2020, according to the National Health Commission of 
People′s Republic of China and WHO. Unfortunately, the number of patients diagnosed 
and death is still on the rise, and no proven effective medicine and/or treatment is 
available thus far for patients contracted this emerging infection. Experience in the 
management of coronavirus epidemic of severe acute respiratory syndrome (SARS) and 
the Middle East respiratory syndrome (MERS) has limited applicability for treating 
COVID-19. The medicine teams from China and all over the world have been fully 
engaged at the frontline to deal with this COVID-19 epidemic.[1] They are also very 
active in conducting many scientific studies on the pathogenesis of the diseases caused 
by this virus, mode of transmission, clinical profiles, management, and disease 
prevention. 
Drug repurposing can quickly find potential therapeutic drugs from drugs with 
known safety, which can be quickly applied to the clinic and solve the treatment 
problems of COVID-19. [1-8] At present, a large number of potential drugs have already 
begun clinical treatment trials of COVID-19. In addition to drugs that can directly 
interact with viruses, a large number of drugs may exert antiviral effects through host 
targets. For example, chloroquine can inhibit the endocytosis of COVID-19 by 
  
 
changing the intracellular environment, increasing the intracellular PH value, etc., so 
as to achieve the antiviral effect; and some drugs targeting the cell pathway may 
produce anti-Coronavirus effects (Antiviral potential of ERK/MAPK and 
PI3K/AKT/mTOR signaling modulation for Middle East respiratory syndrome 
coronavirus infection as identified by temporal kinome analysis). 
Due to the virus invasion, replication and release are highly host-dependent, 
therefore, analyzing the effect of drugs on cells is very important to find effective 
antiviral drugs. Transcriptome, proteome data and other information are the direct 
influence of drugs on intracellular molecules, which is very helpful for the discovery of 
new uses of drugs. However, due to the complexity of the image data itself and the fact 
that it does not directly reflect the molecular characteristics, it is still difficult to use the 
image data for drug function discovery despite its relatively low cost. In this study, by 
analyzing the image data of 1024 drugs acting on cells, the mode of action of the drugs 
was found. In terms of mechanism of action, 1024 drugs represent more than 300 
different mechanisms of action. Fewer samples and more classifications make it 
difficult for machine learning methods to effectively use these data for action pattern 
identification. Because the multi-dimensional features of the image are affected by non-
experimental factors, the characteristics of similar drugs vary greatly, and the current 
sample number is not enough to use deep learning and other methods are used for 
learning optimization. [2-9] As a consequence, this study is based on the supervised 
ITML algorithm to convert the characteristics of drugs. The results show that the 
characteristics of ITML conversion are more conducive to the recognition of drug 
  
 
functions. In this paper, 1105 drugs are analyzed by clustering algorithm in machine 
learning. At the same time, this paper also uses a variety of data preprocessing methods 
to improve the clustering effect. In data preprocessing, this paper compares Principal 
Component Analysis (PCA) algorithm and metric learning algorithm and in data 
clustering we use Affinity Propagation (AP) algorithm.[10-14] Therefore, we adopted the 
ITML algorithm to achieve the identification of drugs with similar mechanisms by 
optimizing the measurement of drug image features. Compared with the original data 
and PCA without the ITML algorithm, this method can help to identify drugs with 
similar mechanisms. For the enrichment analysis of drug types with a sample size 
exceeding 5, it is found that 39 clusters were enriched with 604 types of drugs, 
suggesting that a variety of cell features may be used to discover the mechanism of 
action (MOA) of the drug. 
 
Material and Methods 
Data Collection 
The cell imaging data set containing 372 drugs was sorted and screened (see 
Methods), 1105 image data (including 812-dimensional image information) 
encompassing cell responses to 372 drugs were collected cumulatively (Supplementary 
Table S1). These 372 drugs represent a broad range of clinical use. These image data 
represent the most intuitive phenotypic effects of these drugs on cells. The image data 
includes 812-dimensional data, including Cells_Area Shape_Area, 
Cells_AreaShape_Compactness, Cells_AreaShape_Eccentricity, etc. The distribution 
  
 
of data in each dimension ranges from +677 to -384, etc. We have adopted the mean 
variance normalization method and after normalization, the data is distributed within 
the range of mean 0 and variance 1. We collected the MoA information of the drugs 
from the LINCS database, which contains a total of 372 kinds of MoA, 49 kinds of 
MoA have 5 or more drugs, and the most MoA has as many as 43 kinds of drugs shared. 
PCA algorithm 
PCA algorithm is an algorithm to analyze the most important components of input 
data, which is often used for data dimensionality reduction in machine learning. 
Through PCA algorithm, we can reduce an n-dimensional vector to an m-dimensional 
vector as follows: 
nmnXPCAmX <= )),(()(  
X (n) is the original data, and X (m) is the output data after mapping the original 
data from the n-dimensional space to the m-dimensional space. Note that PCA 
algorithm can not only reduce the dimension of input data, but also extract the more 
effective features in origin data. 
 
Metric learning 
In addition to PCA algorithm, this paper also uses metric learning method to 
preprocess input data before clustering. We use Information-theoretic metric 
learning(ITML) algorithm in metric learning to learn the similarity between input data.  
Metric learning is a machine learning algorithm for learning the similarity between 
data, which is widely used in face recognition and other fields. Metric learning classifies 
  
 
the similarity of input data by learning the distance function in a specific task. 
Compared with the deep learning method, metric learning is more practical. For 
example, the deep learning model trained in a specific task can only adapt to the data 
similar to the training samples, [10-14] and for the input data with large differences from 
the sample data, the results tend to have large errors. At the same time, when the 
categories of data increase, the former training model needs to be retrained under the 
new categories, which will cause a lot of resource and time consumption. Therefore, 
deep learning method is often limited in practical application. As a kind of machine 
learning, metric learning can solve this problem well. It makes the similarity between 
the same type of data increase, and the similarity between different types of data 
decrease. Obviously, the result of data clustering after metric learning will be more 
accurate. In this paper, we use ITML algorithm to preprocess the input data as follows: 
)(S nn nmInputITML ×× =  
nnnmnm SInputOutput ××× ×=  
Inputm×n is the input data, m is the number of input data, n is the dimension of input 
data. Sn×n is the similarity matrix learned by metric learning, and Outputm×n is the output 
data after metric learning. In Outputm×n, the distance between similar classes of drugs 
will be closer than the original data, and the distance between different classes of drugs 
will be farther than the original data. 
AP clustering 
After data preprocessing, we cluster the data. There are many clustering algorithms, 
including unsupervised clustering algorithm and supervised clustering algorithm. 
  
 
Among them, supervised clustering algorithms often need some prior conditions, such 
as the categories that need clustering. Unsupervised clustering algorithm often does not 
need a priori condition, but through the analysis of input data, such as the density or 
mean of input data. The unsupervised clustering algorithm has a good effect on some 
data which is difficult to label or assign a category. In this paper, we use unsupervised 
clustering algorithm Affinity Propagation(AP) to cluster. 
 
Figure 0. The distance plots for data distribution. 
Results and Discussions 
It is found that the currently effective drugs for COVID-19, chloroquine and 
hydroxychloroquine, although not the same on the MoAs label, have similar drug 
characteristics. On the one hand, they can inhibit T cell proliferation and reduce the 
release of proinflammatory cytokines, which can increase the pH of endosome and 
block endocytosis. They can all appear in category 21. This result indicates that their 
common mechanism is related to the DIP after they act on the cells. The other drugs in 
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the cluster are not the same as the known mechanisms of action of these drugs, 
suggesting that they may also have similar effects. The other drugs contained in cluster 
21 have different mechanisms of action. These DIP-like drugs may have similar effects 
in antiviral. The MoA of Clomifene in cluster 21 is annotated as Estrogen receptor 
antagonist, which has been found to be resistant to Ebola, suggesting that it may have 
a similar mechanism of action. This research work laid the foundation for the discovery 
of a new drug mechanism based on image data, and at the same time provided a new 
method for COVID19 drug relocation. In the next step, we will conduct antiviral 
screening experiments on some new predicted drugs. 
 
Cell imaging dataset containing 1105 drugs 
The cell imaging data set containing 372 drugs was sorted and screened (see 
Methods), 1105 image data (including 812-dimensional image information) 
encompassing cell responses to 372 drugs were collected cumulatively (Supplementary 
Table S1). These 372 drugs represent a broad range of clinical use. These image data 
represent the most intuitive phenotypic effects of these drugs on cells. The image data 
includes 812-dimensional data, including Cells_Area Shape_Area, 
Cells_AreaShape_Compactness, Cells_AreaShape_Eccentricity, etc. The distribution 
of data in each dimension ranges from +677 to -384, etc, ，and more than 98.8% of 
the data is between -20 and 20. We have adopted the mean variance normalization 
method and after normalization, the data is distributed within the range of mean 0 and 
variance 1. The data in each dimension follows a positive distribution with a mean of 0 
  
 
and a variance of 1, in which the maximum value is 13.934 and the minimum value is 
-7.930. The original data distribution diagram is shown in Figure 1a, and the normalized 
data distribution diagram is shown in Figure 1b. 
   
Figure1a Origin_data                   Figure1b Norm_data 
 
Figure 1c 
Figure 1. Data distribution plots (a) data distribution for original data, (b) the normalized data 
distribution. (c) The relevant data distribution, in which the pie chart with MoA; the following 
five types are not represented in the pie chart. The top 10 MoA types are presented as a bar 
chart. 
 
We collected the MoA information of the drugs from the LINCS database, which 
  
 
contains a total of 372 kinds of MoA, 49 kinds of MoA have 5 or more drugs, and the 
most MoA has as many as 43 kinds of drugs shared. The types that contain the most 
drugs include Adrenergic receptor antagonist，Dopamine receptor antagonist，
Cyclooxygenase inhibitor 和 Serotonin receptor antagonist. The relevant data 
distribution is shown in Figure 1c (the pie chart represents MoA, and the following 5 
types are not represented in the pie chart. The Top 10 is made into a bar chart) 
The overall flowchart in this work is illustrated in Figure 2. 
 
Figure 2. Overall flowchart of the present study. 
 
ITML to Realize the 812-dimensional image data conversion 
In computer vision research, different features are not the same for the 
classification value applied to different purposes. The same group of pictures can be 
classified according to different attributes such as shape, color, size and so on. 
Supervised learning methods, such as deep learning, can automatically discover more 
efficient classification methods based on the training set. However, when faced with 
  
 
smaller data, the performance of these models is greatly reduced. In general image 
recognition tasks, such as human photo recognition, we can manually select a suitable 
feature and construct a distance function. If our goal is to recognize a human face, then 
we need to build a distance function to strengthen the appropriate feature Such as hair 
color, face shape, etc., if our goal is to recognize posture, then we need to build a 
distance function that captures the similarity of posture. This artificially constructed 
feature often consumes a lot of human effort and may not be robust to data changes. 
ITML as a supervised global metric learning method is an alternative method,[10-14] 
which can learn the metric distance function for a specific task according to different 
learning tasks.  
 
Figure3a                           Figure3b 
Figure 3. TSNEplot of original data, and TSNE plot of ITML-processed data. 
 
As a supervised global metric learning method, ITML is an alternative method. It 
can learn the metric distance function for a specific task according to different learning 
tasks. We use the ITML method to learn the distance measurement of the drug MoA 
classification task, where num_constraints (number of constraints to generate) = 20, 
  
 
max_iter = 1000, convergence_threshold = 0.001. The TSNE graphs of the Top ten 
drugs before and after learning is given in Figure 3 A and Figure 3 B. Through training 
for all drugs’ MoA, we get the T matrix, and the 812-dimensional vector is transformed 
to be a new vector via supervised learning after passing through the T matrix. 
 
Drugs divided into 39 categories based on ITML-transformed features 
We use the T-matrix transformed features to establish drug image phenotype (DIP) 
connections. The DIP connections were represented as an “association score” and 
computed with Euler distance. A total of 609960 pairs of DIP connections (Distance 
Matrix) among 1105 drugs were shown in a heat map representation of Figure 
3b(heatmap of the Distance Matrix).  
 
Figure 4. Heatmap figure of data. 
Application of an automated, parameter-free clustering algorithm yielded 39 drug 
groups with prominent consensus internal DIP similarities.[13,14] We distinguished each 
of these 39 groups as an DIP community (Figure 3a，clustering figure). We use MoA 
composed of more than 5 drugs as a test set for whether the DIP community can be used 
for drug MoA discovery. Our enrichment analysis identified significant (P<0.01) 
  
 
enriched community-specific drug MoAs for each DIP community (Figure 3b and 
Supplementary Table S*，to give what the MoA is enriched by each cluster). Notably, 
Communities 18,36,29 and 34 were enriched with Protein synthesis inhibitor, 
Cytochrome P450 inhibitor, Calmodulin antagonist and Phosphodiesterase inhibitor, 
respectively.  
To examine whether ITML can help MOA recognition, we compared the effect of 
MOA recognition using raw data and data processed by PCA algorithm. Using the 
original data and the data processed by the PCA algorithm for clustering, 57 and 48 
clusters were obtained, and the frequency of enriched MOA was 26 and 24, respectively. 
The enrichment ratio is 0.4561 and 0.5000, which is also lower than the results of ITML. 
Therefore, clustering the ITML-processed data makes it easier to find drugs with 
consistent MoA. 
 
a                           b 
  
 
 
c 
Figure 5. The data clustering figures for a) origin data, b) ITML data, and c) PCA data, 
respectively.  
 
1105 kinds of drugs are enriched in the ITML feature classification results 
1105 drug MoAs were enriched in the 39 classification communities. Serveral 
similar drug MoAs were enriched in same communities. Such as the Protein synthesis 
inhibitors and HDAC inhibitors were both enriched in community 18. The Cytochrome 
P450 inhibitors, and EGFR inhibitors were all enriched in community 36.  The 
Acetylcholine receptor agonists, Bacterial cell wall synthesis inhibitors, and 
Angiogenesis inhibitors were all enriched in community 2.  The Acetylcholine 
receptor antagonists, Retinoid receptor agonists and Tyrosine kinase inhibitors were all 
enriched in community 4. Such overlap may be a random phenomenon, which may 
imply that two different MoA drugs cause similar cell phenotypes. We found that 
Adrenergic receptor agonist, Norepinehrine reuptake inhibitor, Aromatic hydrocarbon 
derivative and other MoA did not significantly enrich in all clusters. The effects of these 
  
 
drugs on the phenotype of tumor cells are not significant, and therefore it may cause 
image data to be non-specific feature. 
DIP facilitate to identify the drug use 
In order to identify which image features may be more conducive to the 
identification of drug use, we calculated the intra-class distance ratio between the 
features of each dimension in each cluster (Table S2 (in the annex)), see the method 
section for details). And determine the Community specific image features (CSIF) 
according to the intra-class ratio <0.01. We found that the CSIF in each cluster rarely 
overlaps, only 26 different features play a role in 2 clusters, and no features are 
simultaneously Become a CSIF of 3 or more Communities. For example, 
Nuclei_Intensity_MeanIntensity_Ph_golgi is the CSIF of cluster 16 of Dopamine 
uptake inhibitor and cluster 22 without enrichment of any kind of drugs. CSIF suggests 
that drugs within clusters may have specific pattern responses on these characteristics. 
We see that although there are only 4 Tubulin inhibitors in the data set, they are all 
concentrated in Community 20. Community 20 is also enriched with CDK inhibitors, 
and the only 2 Microtubule inhibitors are all in this cluster. The CSIF corresponding to 
this Community is Cells_Texture_InfoMeas1_Hoechst_5, 
Cells_Texture_InfoMeas2_Ph_golgi_5, Cells_Texture_Variance_Hoechst_3, 
Cytoplasm_AreaShape_Zernike_8_8. This may be related to the effect of the above 
drugs on the cell cycle, inhibiting the division of cells and causing changes in cell 
texture. These results suggest that it is feasible to discover the function of drugs or new 
compounds based on DIP (See Table S1 in the attachment for more details). It is found 
  
 
that the COVID-19 prevention and treatment drugs are in cluster 21. The above research 
results show that the effect of drugs on cells will be through multi-dimensional image 
features, and the use of ITML for feature conversion will help us find similar drugs. 
This feature can help us to find more drugs with similar mechanisms through the 
similarity of drug phenotypes. At present, COVID-19 still lacks effective drugs. 
Chloroquine, redisevir and other drugs may be candidate drugs with certain effects. 
Drugs such as ridxivir target viral proteins, and DIP derived from uninfected cell lines 
may not be able to reflect drug functions. Chloroquine exerts an anti-infective effect on 
the host. However, serious side effects of drugs such as chloroquine may limit its use. 
Therefore, the discovery of new alternative drugs through DIP is also of great 
significance. We found that the currently effective drugs for COVID19, chloroquine 
and hydroxychloroquine, although not the same on the MoAs label, have similar drug 
characteristics. On the one hand, they can inhibit T cell proliferation and reduce the 
release of proinflammatory cytokines. , It can increase the pH of endosome and block 
endocytosis. They can all appear in category 21. The CSIFs of the drugs in the cluster 
include Nuclei_Intensity_IntegratedIntensity_Mito, 
Nuclei_Texture_InfoMeas1_Mito_3, and so on. The result indicates that their common 
mechanism is related to the DIP after they act on the cells. The other drugs in the cluster 
are not the same as the known mechanisms of action of these drugs, suggesting that 
they may also have similar effects. The other drugs contained in cluster 21 have 
different mechanisms of action. These DIP-like drugs may have similar effects in 
antiviral. The MoA of Clomifene in cluster 21 is annotated as Estrogen receptor 
  
 
antagonist, which has been found to be resistant to Ebola, suggesting that it may have 
a similar mechanism of action. The image data after the drug acts on the cell is one of 
the most easily obtained screening data. Judging the potential effects of drugs from 
images has great application value. Here we use the cell characteristic data processed 
by professional cell image processing software (cellprofiler) to predict MoA. Due to 
the complex MoA of drugs, we use third-party MoA annotation data and optimize the 
metrics based on ITML. The optimized cluster is more closely related to the known 
MoA. Next, we found that the clustering results based on image features are closely 
related to the MoA of the drug itself. Such as Tubulin inhibitors, CDK inhibitors and 
Microtubule inhibitors can inhibit the formation of spindles, and they are 
simultaneously classified into cluster 20. The COVID-19 drug candidates chloroquine 
and hydroxychloroquine, and the anti-Ebola drug clomiphene appeared in cluster 21 at 
the same time. Although their MoA annotations are different, they can inhibit the entry 
of the virus, and on multiple image features Have similarities. These results confirm the 
possibility and accuracy of drug discovery based on cell image data. It should be noted 
that the cell image data we used came from a cell line without SARS-CoV-2 infection. 
Therefore, drugs that target viral proteins may not have a consistent effect on the image 
of this cell infection, so these data may not be applicable to virus-targeted drug 
discovery. The image data of the effect of drugs on SARS-CoV-2 infected cells may be 
used to screen virus-targeted drugs. 
 
Conclusions 
  
 
In summary, the functional and association analysis of DIPs provided a hypothesis 
for drug repurposing of MOA. The present study here indicates that their common 
mechanism is related to the DIP after they act on the cells. The other drugs in the cluster 
are not the same as the known mechanisms of action of these drugs, suggesting that 
they may also have similar effects. The other drugs contained in cluster 21 have 
different mechanisms of action. The results show that the characteristics of ITML 
conversion are more conducive to the recognition of drug functions. The analysis of 
feature conversion shows that different features play important roles in identifying 
different drug functions. For the current COVID-19, Chloroquine and 
Hydroxychloroquine achieve antiviral effects by inhibiting endocytosis, etc., and were 
classfied to the same community. And Clomiphene in the same community inibited the 
entry of Ebola Virus, indicated similar MoAs with Chloroquine and 
Hydroxychloroquine that could be reflected by cell image. The MoA of Clomifene in 
cluster 21 is annotated as Estrogen receptor antagonist, which has been found to be 
resistant to Ebola, suggesting that it may have a similar mechanism of action. In future, 
antiviral screening experiments on some new predicted drugs will be conducted.The 
present work laid the foundation for the discovery of a new MOA of drug based on 
machine learning of image data, and at the same time provided a new way for the 
COVID-19 drug relocation.  
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